143 related articles for article (PubMed ID: 32079866)
1. Somatic Mutation Profile of Atypical Fibroxanthoma and Cutaneous Undifferentiated Pleomorphic Sarcoma.
Lim YH; Zaki TD; Levinsohn JL; Galan A; Choate KA; Hanlon AM
Dermatol Surg; 2021 Feb; 47(2):290-292. PubMed ID: 32079866
[No Abstract] [Full Text] [Related]
2. Clinicopathological and Genomic Profiles of Atypical Fibroxanthoma and Pleomorphic Dermal Sarcoma Identify Overlapping Signatures with a High Mutational Burden.
Ak M; Kahraman A; Arnold FM; Turko P; Levesque MP; Zoche M; Ramelyte E; Dummer R
Genes (Basel); 2021 Jun; 12(7):. PubMed ID: 34202213
[TBL] [Abstract][Full Text] [Related]
3. TERT promoter mutations are frequent in atypical fibroxanthomas and pleomorphic dermal sarcomas.
Griewank KG; Schilling B; Murali R; Bielefeld N; Schwamborn M; Sucker A; Zimmer L; Hillen U; Schaller J; Brenn T; Schadendorf D; Mentzel T
Mod Pathol; 2014 Apr; 27(4):502-8. PubMed ID: 24030750
[TBL] [Abstract][Full Text] [Related]
4. Atypical fibroxanthoma and pleomorphic dermal sarcoma harbor frequent NOTCH1/2 and FAT1 mutations and similar DNA copy number alteration profiles.
Griewank KG; Wiesner T; Murali R; Pischler C; Müller H; Koelsche C; Möller I; Franklin C; Cosgarea I; Sucker A; Schadendorf D; Schaller J; Horn S; Brenn T; Mentzel T
Mod Pathol; 2018 Mar; 31(3):418-428. PubMed ID: 29099504
[TBL] [Abstract][Full Text] [Related]
5. Atypical Fibroxanthoma.
López L; Vélez R
Arch Pathol Lab Med; 2016 Apr; 140(4):376-9. PubMed ID: 27028396
[TBL] [Abstract][Full Text] [Related]
6. Pleomorphic dermal sarcoma in a man with HIV: report with next-generation sequencing analysis and review of the atypical fibroxanthoma/pleomorphic dermal sarcoma spectrum.
Chen SX; Eichenfield DZ; Orme C; Hinds B
Dermatol Online J; 2019 Nov; 25(11):. PubMed ID: 32045146
[TBL] [Abstract][Full Text] [Related]
7. Oncogene and therapeutic target analyses in atypical fibroxanthomas and pleomorphic dermal sarcomas.
Helbig D; Ihle MA; Pütz K; Tantcheva-Poor I; Mauch C; Büttner R; Quaas A
Oncotarget; 2016 Apr; 7(16):21763-74. PubMed ID: 26943575
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the lymphatic vessel architecture of atypical fibroxanthoma and pleomorphic dermal sarcoma.
Zschoche C; Hamsch C; Kutzner H; Mentzel T; Werchau S; Enk A; Hartschuh W; Hadaschik E; Toberer F
J Am Acad Dermatol; 2014 Oct; 71(4):842-5. PubMed ID: 25219715
[No Abstract] [Full Text] [Related]
9. Pleomorphic Dermal Sarcoma.
Saleh JS; Whittington CP; Bresler SC; Patel RM
Surg Pathol Clin; 2024 Mar; 17(1):153-158. PubMed ID: 38278604
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical expression of melanocytic and myofibroblastic markers and their molecular correlation in atypical fibroxanthomas and pleomorphic dermal sarcomas.
Helbig D; Mauch C; Buettner R; Quaas A
J Cutan Pathol; 2018 Dec; 45(12):880-885. PubMed ID: 30155964
[TBL] [Abstract][Full Text] [Related]
11. Pleomorphic dermal sarcoma: adverse histologic features predict aggressive behavior and allow distinction from atypical fibroxanthoma.
Miller K; Goodlad JR; Brenn T
Am J Surg Pathol; 2012 Sep; 36(9):1317-26. PubMed ID: 22510760
[TBL] [Abstract][Full Text] [Related]
12. Atypical fibroxanthoma with pseudoangiomatous features: a histological and immunohistochemical mimic of cutaneous angiosarcoma.
Thum C; Husain EA; Mulholland K; Hornick JL; Brenn T
Ann Diagn Pathol; 2013 Dec; 17(6):502-7. PubMed ID: 24080496
[TBL] [Abstract][Full Text] [Related]
13. Aberrant Melan-A expression in atypical fibroxanthoma and undifferentiated pleomorphic sarcoma of the skin.
Thum C; Hollowood K; Birch J; Goodlad JR; Brenn T
J Cutan Pathol; 2011 Dec; 38(12):954-60. PubMed ID: 22050092
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous undifferentiated pleomorphic sarcoma is a pleomorphic dermal sarcoma.
Cohen PR
Dermatol Online J; 2020 May; 26(5):. PubMed ID: 32621710
[TBL] [Abstract][Full Text] [Related]
15. Atypical Fibroxanthoma and Pleomorphic Dermal Sarcoma: Updates on Classification and Management.
Soleymani T; Aasi SZ; Novoa R; Hollmig ST
Dermatol Clin; 2019 Jul; 37(3):253-259. PubMed ID: 31084719
[TBL] [Abstract][Full Text] [Related]
16. Undifferentiated Sarcoma as Intermediate Step in the Progression of Malignant Melanoma to Rhabdomyosarcoma: Histologic, Immunohistochemical, and Molecular Studies of a New Case of Malignant Melanoma With Rhabdomyosarcomatous Differentiation.
Tran TAN; Linos K; de Abreu FB; Carlson JA
Am J Dermatopathol; 2019 Mar; 41(3):221-229. PubMed ID: 30085960
[TBL] [Abstract][Full Text] [Related]
17. A genomic survey of sarcomas on sun-exposed skin reveals distinctive candidate drivers and potentially targetable mutations.
Miller TI; Zoumberos NA; Johnson B; Rhodes DR; Tomlins SA; Chan MP; Andea AA; Lucas DR; McHugh JB; Smith N; Harms KL; Brewer C; Saleh J; Patel RM; Harms PW
Hum Pathol; 2020 Aug; 102():60-69. PubMed ID: 32540221
[TBL] [Abstract][Full Text] [Related]
18. Atypical Fibroxanthoma Revisited.
Mentzel T; Requena L; Brenn T
Surg Pathol Clin; 2017 Jun; 10(2):319-335. PubMed ID: 28477883
[TBL] [Abstract][Full Text] [Related]
19. CGH analysis shows genetic similarities and differences in atypical fibroxanthoma and undifferentiated high grade pleomorphic sarcoma.
Mihic-Probst D; Zhao J; Saremaslani P; Baer A; Oehlschlegel C; Paredes B; Komminoth P; Heitz PU
Anticancer Res; 2004; 24(1):19-26. PubMed ID: 15015571
[TBL] [Abstract][Full Text] [Related]
20. Atypical fibroxanthoma: new insights.
Hussein MR
Expert Rev Anticancer Ther; 2014 Sep; 14(9):1075-88. PubMed ID: 24958232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
